Weinberg Laurence, Collins Neil, Van Mourik Kiara, Tan Chong, Bellomo Rinaldo
Laurence Weinberg, Department of Surgery, Perioperative Pain Medicine Unit, University of Melbourne, Victoria 3084, Australia.
World J Crit Care Med. 2016 Nov 4;5(4):235-250. doi: 10.5492/wjccm.v5.i4.235.
To outline the physiochemical properties and specific clinical uses of Plasma-Lyte 148 as choice of solution for fluid intervention in critical illness, surgery and perioperative medicine.
We performed an electronic literature search from Medline and PubMed ( Ovid), anesthesia and pharmacology textbooks, and online sources including studies that compared Plasma-Lyte 148 to other crystalloid solutions. The following keywords were used: "surgery", "anaesthesia", "anesthesia", "anesthesiology", "anaesthesiology", "fluids", "fluid therapy", "crystalloid", "saline", "plasma-Lyte", "plasmalyte", "hartmann's", "ringers" "acetate", "gluconate", "malate", "lactate". All relevant articles were accessed in full. We summarized the data and reported the data in tables and text.
We retrieved 104 articles relevant to the choice of Plasma-Lyte 148 for fluid intervention in critical illness, surgery and perioperative medicine. We analyzed the data and reported the results in tables and text.
Plasma-Lyte 148 is an isotonic, buffered intravenous crystalloid solution with a physiochemical composition that closely reflects human plasma. Emerging data supports the use of buffered crystalloid solutions in preference to saline in improving physicochemical outcomes. Further large randomized controlled trials assessing the comparative effectiveness of Plasma-Lyte 148 and other crystalloid solutions in measuring clinically important outcomes such as morbidity and mortality are needed.
概述148毫渗量乳酸钠林格注射液(Plasma-Lyte 148)的理化性质及其作为危重病、手术及围手术期医学液体干预首选溶液的具体临床用途。
我们通过检索医学文献数据库(Medline)和医学期刊数据库(PubMed,Ovid平台)、麻醉学和药理学教科书以及在线资源,纳入了比较148毫渗量乳酸钠林格注射液与其他晶体溶液的研究。检索关键词如下:“手术”、“麻醉”、“麻醉学”、“液体”、“液体疗法”、“晶体液”、“生理盐水”、“148毫渗量乳酸钠林格注射液”、“乳酸林格液”、“复方氯化钠注射液”、“醋酸盐”、“葡萄糖酸盐”、“苹果酸盐”、“乳酸盐”。获取了所有相关文章的全文。我们对数据进行了总结,并以表格和文字形式呈现。
我们检索到104篇与148毫渗量乳酸钠林格注射液作为危重病、手术及围手术期医学液体干预选择相关的文章。我们对数据进行了分析,并以表格和文字形式报告了结果。
148毫渗量乳酸钠林格注射液是一种等渗、缓冲的静脉晶体溶液,其理化成分与人体血浆极为相似。新出现的数据支持在改善理化指标方面优先使用缓冲晶体溶液而非生理盐水。需要进一步开展大型随机对照试验,以评估148毫渗量乳酸钠林格注射液和其他晶体溶液在衡量发病率和死亡率等临床重要结局方面的相对有效性。